Video Latest - ecancer

Precision approaches for immunotherapy

Dr Eric H Rubin - Senior Vice President Global Clinical Development, Oncology Early Development, MSD

10 Jul 2018

Beyond standard of care: the next steps of Precision Oncology

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain

9 Jul 2018

21st century medicine is transforming healthcare and the diagnosis and treatment of cancer

Dr Leroy Hood - Institute For Systems Biology, Seattle, USA

9 Jul 2018

The TAPUR trial family: a global data sharing platform

Dr Richard Schilsky - American Society Of Clinical Oncology, USA

9 Jul 2018

The 10th Anniversary of the WIN Consortium: lessons and perspectives

Dr Richard Schilsky - American Society Of Clinical Oncology, USA

9 Jul 2018

U.S. National Cancer Institute perspective on precision oncology

Dr James Doroshow - National Cancer Institute, NIH, Bethesda, USA

6 Jul 2018

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA

6 Jul 2018

Implementing precision medicine in oncology: The IMPACT trials

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA

6 Jul 2018

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

4 Jul 2018

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

24 Jun 2018

Treating CLL with obinutuzumab

Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany

17 Jun 2018

Isatuximab in combination to treat relapsed/refractory MM

Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma Foundation

$Isatuximab in combination to treat relapsed/refractory MM ( Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma Foundation )$

17 Jun 2018

Video